A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JMT202
Clinical trial NCT06564467 · UNKNOWN
Trial details
- NCT number
- NCT06564467
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-23
- Primary completion
- 2025-01-10
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.